Latest reported quarter: Q2, ended Jun 2026
Quarter 2025/FY
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $727.09M | $633.00M | $3.06B | $790.61M | $632.00M |
| Total Operating Revenue | $727.09M | $633.00M | $3.06B | $790.61M | $632.00M |
| Cost of Revenue | $821.90M | $653.00M | $4.14B | $1.56B | $567.00M |
| Gross Profit | -$94.81M | -$20.00M | -$1.08B | -$768.12M | $65.00M |
| Net Profit | -$459.45M | -$383.00M | -$2.36B | -$1.03B | -$166.00M |
| Profit from Continuing Operations | -$459.45M | -$383.00M | -$2.36B | -$1.03B | -$166.00M |
| Net Income to Parent Company | -$459.45M | -$383.00M | -$2.36B | -$1.03B | -$166.00M |
| Net Income to Common Stockholders | -$459.45M | -$383.00M | -$2.36B | -$1.03B | -$166.00M |
| Basic EPS | -$2.80 | -$2.64 | -$25.50 | -$14.54 | -$2.36 |
| Diluted EPS | -$2.80 | -$2.64 | -$25.50 | -$14.54 | -$2.36 |
| Operating Expense | – | – | $902.60M | – | – |
| Selling and Admin Expenses | – | – | $813.85M | – | – |
| -Selling & Marketing Expense | – | – | $409.42M | – | – |
| -General & Admin Expense | – | – | $404.43M | – | – |
| Research & Development | – | – | $77.64M | – | – |
| Depreciation & Amortization & Depletion | – | – | $23.40M | – | – |
| -Depreciation & Amortization | – | – | $23.40M | – | – |
| Other Taxes | – | – | $2.30M | – | – |
| Other Operating Expenses | – | – | -$14.58M | – | – |
| Operating Profit | – | – | -$1.99B | – | – |
| Net Non-Operating Interest Income (Expense) | – | – | -$376.19M | – | – |
| Non-Operating Interest Income | – | – | $7.64M | – | – |
| Non-Operating Interest Expense | – | – | $375.23M | – | – |
| Total Other Finance Costs | – | – | $8.61M | – | – |
| Other Income (Expense) | – | – | $1.78M | – | – |
| Gain on Sale of Security | – | – | $94.43M | – | – |
| Earnings from Equity Interest | – | – | -$49.15M | – | – |
| Special Income (Charges) | – | – | -$43.50M | – | – |
| -Less:Restructuring and Mergern & Acquisition | – | – | $44.17M | – | – |
| -Less:Impairment of Capital Assets | – | – | $0.00 | – | – |
| -Gain on Sale Of Business | – | – | $666,000.00 | – | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | $0.00 | – | – |
| Pretax Profit | – | – | -$2.36B | – | – |
| Tax | – | – | -$3.69M | – | – |
| Line item | 2026 Q2 | 2025 ANNUAL | 2025 Q2 | 2024 ANNUAL | 2024 Q2 |
|---|---|---|---|---|---|
| Total Assets | $3.52B | $3.93B | $3.64B | $4.05B | $3.83B |
| Total Current Assets | $2.24B | $2.69B | $2.21B | $2.30B | $1.84B |
| Cash and Cash Equivalents & Short-Term Investments | $887.58M | $1.16B | $718.63M | $739.24M | $668.91M |
| -Cash and Cash Equivalents | $887.58M | $1.16B | $718.63M | $739.24M | $668.91M |
| Receivables | $381.88M | $511.57M | $419.41M | $398.11M | – |
| -Accounts Receivable | $363.89M | $341.88M | $336.20M | $233.09M | – |
| -Taxes Receivable | $18.00M | $139.60M | $10.20M | $153.43M | – |
| Inventory | $719.99M | $853.08M | $805.70M | $1.08B | – |
| Other Current Assets | $251.17M | $73.37M | $270.28M | $32.42M | $1.17B |
| Total Non-Current Assets | $1.28B | $1.24B | $1.43B | $1.76B | $1.99B |
| Net PPE | $435.10M | $393.53M | $343.61M | $593.88M | – |
| -Gross PPE | $1.13B | $1.07B | $795.91M | $969.10M | – |
| -Accumulated Depreciation | -$696.40M | -$679.65M | -$452.30M | -$375.22M | – |
| Goodwill and Other Intangible Assets | $663.42M | $700.33M | $837.67M | $1.04B | – |
| -Goodwill | $49.71M | $52.39M | $53.32M | $43.79M | – |
| -Other Intangible Assets | $613.71M | $647.94M | $784.35M | $997.06M | – |
| Non-Current Deferred Assets | $94.53M | $92.35M | $123.38M | $81.55M | – |
| Other Non-Current Assets | $82.90M | $38.93M | $124.03M | $31.01M | – |
| Total Liabilities | $8.25B | $9.05B | $7.91B | $7.38B | $5.65B |
| Total Current Liabilities | $6.94B | $6.21B | $5.20B | $4.74B | $3.04B |
| Payables | $906.02M | $1.29B | $805.79M | $1.08B | – |
| -Accounts Payable | $894.80M | $1.11B | $757.74M | $893.91M | – |
| -Total Tax Payable | $11.22M | $174.36M | $5.35M | $144.37M | – |
| Current Accrued Expenses | $320.88M | $424.58M | $280.78M | $519.76M | – |
| Short-Term Debt and Capital Lease Obligation | $4.99B | $3.90B | $3.21B | $2.69B | – |
| -Current Debt | $4.96B | $3.86B | $3.20B | $2.66B | – |
| -Current Capital Lease Obligation | $28.64M | $37.21M | $14.54M | $30.92M | – |
| Current Provisions | $115.31M | $288.43M | $114.76M | $173.61M | – |
| Current Deferred Liabilities | $43.75M | $53.25M | $37.33M | $54.99M | – |
| Other Current Liabilities | $571.33M | $203.17M | $751.19M | $194.12M | – |
| Total Non-Current Liabilities | $1.31B | $2.84B | $2.71B | $2.64B | $2.61B |
| Long Term Debt and Capital Lease Obligation | $1.03B | $2.59B | $2.43B | $2.39B | – |
| -Long Term Debt | $946.82M | $2.50B | $2.38B | $2.28B | – |
| -Long Term Capital Lease Obligation | $84.46M | $93.51M | $50.29M | $104.35M | – |
| Non-Current Liabilities | $120.49M | $133.54M | $104.20M | $94.76M | – |
| Non-Current Deferred Liabilities | $70.72M | $76.67M | $74.73M | $61.63M | – |
| Other Non-Current Liabilities | $83.36M | $40.81M | $94.36M | $100.18M | – |
| Total Equity | -$4.73B | -$5.12B | -$4.27B | -$3.33B | -$1.82B |
| Stockholders' Equity | -$4.73B | -$5.12B | -$4.27B | -$3.33B | -$1.82B |
| Capital Stock | $49.35M | $27.82M | $21.26M | $21.17M | – |
| -Common Stock | $49.35M | $27.82M | $21.26M | $21.17M | – |
| Additional Paid-In Capital | $5.44B | $4.13B | $3.85B | $3.63B | – |
| Retained Earnings | -$10.11B | -$9.27B | -$8.10B | -$6.91B | – |
| Gains/Losses Not Affecting Retained Earnings | -$106.26M | -$14.66M | -$28.28M | -$63.15M | – |
| -Due from Related Parties Current | – | $2.83M | $17.10M | $2.71M | – |
| -Other Receivables | – | $27.26M | $55.90M | $8.89M | – |
| Prepaid Assets | – | $36.31M | – | $49.20M | – |
| Restricted Cash | – | $55.04M | – | $0.00 | – |
| Non Current Accounts Receivables | – | $16.01M | – | $8.73M | – |
| -Due to Related Parties Current | – | $11.58M | $42.70M | $39.64M | – |
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2024 Q2 | 2024 Q1 | 2023 ANNUAL |
|---|---|---|---|---|---|
| Operating Cash Flow | -$914.99M | -$991.21M | -$38.60M | -$229.08M | -$1.89B |
| Net cash flow from continuing operations | -$914.99M | -$991.21M | – | – | -$1.89B |
| Net Income from Continuing Operations | -$2.36B | -$2.05B | – | – | -$1.18B |
| Gain/Loss from Continuing Operations | $14.83M | $72.96M | – | – | $27.41M |
| Depreciation & Depletion & Amortization | $52.72M | $55.72M | – | – | $115.45M |
| Deferred Tax | -$3.69M | -$9.17M | – | – | -$9.45M |
| Other Non-Cash Items | $394.48M | $206.17M | – | – | -$267.52M |
| Change in Working Capital | -$35.87M | $252.84M | – | – | -$926.67M |
| -Change in Receivables | -$134.05M | $85.02M | – | – | -$156.86M |
| -Change in Inventory | $292.23M | -$255.37M | – | – | -$358.39M |
| -Change in Payables and Accrued Expense | -$170.20M | $464.89M | – | – | -$488.84M |
| -Change In Other Working Capital | -$23.85M | -$41.70M | – | – | $77.42M |
| Net cash flow from investing | -$520.68M | -$412.56M | -$84.65M | -$188.04M | -$417.62M |
| Net Cash Flow from Continuing Investing Activities | -$520.68M | -$412.56M | – | – | -$417.62M |
| Net PPE Purchase and Sale | -$153.70M | -$147.86M | – | – | -$135.62M |
| Net Intangibles Purchase and Sale | -$296.08M | -$209.10M | – | – | -$435.58M |
| Net Business Purchase and Sale | -$63.70M | -$34.30M | – | – | $0.00 |
| Net Other Investing Changes | -$7.20M | -$21.30M | – | – | $153.59M |
| Financing Cash Flow | $1.69B | $1.42B | -$2.13M | $463.52M | $2.10B |
| Net Cash Flow from Continuing Financing Activities | $1.69B | $1.42B | – | – | $2.10B |
| Net Issuance Payments Of Debt | $1.19B | $1.42B | – | – | $2.08B |
| Net Common Stock Issuance | $498.34M | $0.00 | – | – | $0.00 |
| Ending Cash Balance | $1.16B | $739.24M | $668.91M | $784.02M | $768.26M |
| Net Change in Cash | $257.43M | $20.42M | -$125.37M | $46.40M | -$207.10M |
| Beginning Cash Balance | $739.24M | $768.26M | $784.02M | $768.93M | $973.88M |
| Effect of Exchange Rate Changes | $162.64M | -$49.45M | $10.92M | -$31.30M | $1.49M |
| Free Cash Flow | -$1.37B | -$1.35B | -$255.53M | -$229.08M | -$2.47B |
| Net Other Financing Charges | – | – | – | – | $23.66M |
No comments yet — be the first to weigh in on PSNYW.